CWG
PRTK

C WorldWide Group’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

C WorldWide Group’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-470,150
Closed -$2.52M – 111
2019
Q1 		$2.52M Hold
470,150
– – 0.03% 84
2018
Q4 		$2.41M Sell
470,150
-38,132
-8% -$290K 0.03% 70
2018
Q3 		$4.93M Sell
508,282
-27,846
-5% -$281K 0.06% 66
2018
Q2 		$5.47M Buy
536,128
+37,875
+8% +$429K 0.08% 62
2018
Q1 		$6.48M Sell
498,253
-116,647
-19% -$1.74M 0.1% 52
2017
Q4 		$11M Sell
614,900
-30,200
-5% -$630K 0.16% 43
2017
Q3 		$16.2M Buy
645,100
+205,700
+47% +$4.79M 0.23% 34
2017
Q2 		$10.6M Buy
439,400
+359,400
+449% +$7.95M 0.16% 48
2017
Q1 		$1.54M Buy
+80,000
New +$1.26M 0.03% 95

Other funds holding PRTK

OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
APCM
Arbiter Partners Capital Management New York $190M AUM 50.42% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

C WorldWide Group's PRTK Position: Q2 2019 in Review

C WorldWide Group sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q2 2019, closing a stake of 470,150 shares — an estimated $2.52M sold.

C WorldWide Group first reported a position in PRTK in Q1 2017 and held it in 9 quarters. The position peaked at $16.2M in Q3 2017. 89 funds tracked by Wall St. Rank hold PRTK as of Q2 2019.

  • C WorldWide Group reported no remaining Paratek Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
  • C WorldWide Group sold 470,150 Paratek Pharmaceuticals, Inc. shares in Q2 2019, an estimated $2.52M.
  • C WorldWide Group first reported a position in Paratek Pharmaceuticals, Inc. in Q1 2017 and held it in 9 quarters.
  • C WorldWide Group's Paratek Pharmaceuticals, Inc. position peaked at $16.2M in Q3 2017.
  • 89 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q2 2019.

Based on C WorldWide Group's 13F filing for Q2 2019, filed 2 Aug 2019.